Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Our compounded formulation is not affiliated with, endorsed by, or intended to replace the FDA-approved product manufactured by Eli Lilly
Hospira, now part of Pfizer, is recognised globally as a trusted manufacturer of pharmaceutical injectables and critical care solutions
Where Semaglutide targets a single receptor and Tirzepatide hits two, Retatrutide simultaneously activates three: GLP-1 (Glucagon-Like Peptide-1): The foundational receptor target for this entire class
Opened vials: yes, refrigerate at 2-8C
Loved every bit of it
US$ 29.75
US$ 25.44
US$ 25.84
US$ 20.77
US$ 28.26
